Zhao J, Meng H, Liao S, Su Y, Guo L, Wang A
J Orthop Translat. 2022; 37:126-142.
PMID: 36313533
PMC: 9582590.
DOI: 10.1016/j.jot.2022.09.008.
Hyun I, Scharf-Deering J, Lunshof J
Brain Res. 2020; 1732:146653.
PMID: 32017900
PMC: 7140135.
DOI: 10.1016/j.brainres.2020.146653.
Guhr A, Kobold S, Seltmann S, Seiler Wulczyn A, Kurtz A, Loser P
Stem Cell Reports. 2018; 11(2):485-496.
PMID: 30033087
PMC: 6092712.
DOI: 10.1016/j.stemcr.2018.06.012.
Kimmelman J, Hyun I, Benvenisty N, Caulfield T, Heslop H, Murry C
Nature. 2016; 533(7603):311-3.
PMID: 27193661
DOI: 10.1038/533311a.
Lee J, Han Y, Lee S
Biomol Ther (Seoul). 2016; 24(3):260-7.
PMID: 26869524
PMC: 4859789.
DOI: 10.4062/biomolther.2015.146.
Human embryonic and induced pluripotent stem cell research trends: complementation and diversification of the field.
Kobold S, Guhr A, Kurtz A, Loser P
Stem Cell Reports. 2015; 4(5):914-25.
PMID: 25866160
PMC: 4437486.
DOI: 10.1016/j.stemcr.2015.03.002.
Ethical issues in stem cell research and therapy.
King N, Perrin J
Stem Cell Res Ther. 2014; 5(4):85.
PMID: 25157428
PMC: 4097842.
DOI: 10.1186/scrt474.
Genome-wide mapping of miRNAs expressed in embryonic stem cells and pluripotent stem cells generated by different reprogramming strategies.
Zhao B, Yang D, Jiang J, Li J, Fan C, Huang M
BMC Genomics. 2014; 15:488.
PMID: 24942538
PMC: 4082626.
DOI: 10.1186/1471-2164-15-488.
Serum-free spheroid suspension culture maintains mesenchymal stem cell proliferation and differentiation potential.
Alimperti S, Lei P, Wen Y, Tian J, Campbell A, Andreadis S
Biotechnol Prog. 2014; 30(4):974-83.
PMID: 24616445
PMC: 5081183.
DOI: 10.1002/btpr.1904.
Progress and prospects for genetic modification of nonhuman primate models in biomedical research.
Chan A
ILAR J. 2013; 54(2):211-23.
PMID: 24174443
PMC: 3814401.
DOI: 10.1093/ilar/ilt035.
Specimen collection for induced pluripotent stem cell research: harmonizing the approach to informed consent.
Lowenthal J, Lipnick S, Rao M, Hull S
Stem Cells Transl Med. 2012; 1(5):409-21.
PMID: 23197820
PMC: 3659701.
DOI: 10.5966/sctm.2012-0029.
Impedance of novel therapeutic technologies: the case of stem cells.
Zacharias D, Nelson T, Mueller P, Hook C
Clin Transl Sci. 2012; 5(5):422-7.
PMID: 23067356
PMC: 5439797.
DOI: 10.1111/j.1752-8062.2012.00434.x.
Communicating risks and benefits about ethically controversial topics: the case of induced pluripotent stem (iPS) cells.
Longstaff H, McDonald M, Bailey J
Stem Cell Rev Rep. 2012; 9(4):388-96.
PMID: 22941397
DOI: 10.1007/s12015-012-9407-2.
The science and ethics of induced pluripotency: what will become of embryonic stem cells?.
Zacharias D, Nelson T, Mueller P, Hook C
Mayo Clin Proc. 2011; 86(7):634-40.
PMID: 21719620
PMC: 3127559.
DOI: 10.4065/mcp.2011.0054.
The ethics of moral compromise for stem cell research policy.
Master Z, Crozier G
Health Care Anal. 2011; 20(1):50-65.
PMID: 21484499
DOI: 10.1007/s10728-011-0171-2.
Cellular models for disease exploring and drug screening.
Li Z, Zhou Q
Protein Cell. 2011; 1(4):355-362.
PMID: 21203947
PMC: 4875092.
DOI: 10.1007/s13238-010-0027-9.
Derivation of new human embryonic stem cell lines from preimplantation genetic screening and diagnosis-analyzed embryos.
Taei A, Gourabi H, Seifinejad A, Totonchi M, Shahbazi E, Rezazadeh Valojerdi M
In Vitro Cell Dev Biol Anim. 2010; 46(3-4):395-402.
PMID: 20177993
DOI: 10.1007/s11626-010-9293-3.
Future alternative therapies for β-thalassemia.
Rivella S, Rachmilewitz E
Expert Rev Hematol. 2010; 2(6):685.
PMID: 20174612
PMC: 2823128.
DOI: 10.1586/ehm.09.56.
Testicular germline stem cells.
Kee K, Pera R, Turek P
Nat Rev Urol. 2010; 7(2):94-100.
PMID: 20084076
DOI: 10.1038/nrurol.2009.263.
The bioethics of stem cell research and therapy.
Hyun I
J Clin Invest. 2010; 120(1):71-5.
PMID: 20051638
PMC: 2798696.
DOI: 10.1172/JCI40435.
